Personalis (PSNL) Peer Comparison

$16.94

$0.14 (0.83%)

As on 28-Aug-2026 13:38EDT

Market cap

$1,962 Mln

Revenue (TTM)

$70 Mln

P/E Ratio

--

P/B Ratio

8.4

Div. Yield

0 %

Edit

	Personalis (PSNL)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)	1,962	17,326	16,614	13,400	12,305
Revenue ($ Mln)	70	2,782	1,054	2,436	670
Net Profit ($ Mln)	-107.18	491.50	755.85	860.62	-319.95
Net Margin (%)	-153.84	17.67	71.69	35.33	-47.79
RoE (%)	-43.19	110.09	--	42.98	-71.14
Price to Earnings	--	36.49	19.38	17.01	--
Price-To-Book	8.35	39.43	10.05	7.27	26.44

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Personalis (PSNL)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Operating Revenue	69.67	2,782.29	1,054.37	2,435.92	669.50
Cost of Revenue	60.83	1,982.07	103.47	85.67	19.14
Gross Profit	15.78	760.62	588.53	2,236.43	829.45
Operating Expenses	123.15	216.81	841.45	1,378.74	895.93
Operating Profit (EBIT)	-114.31	583.40	109.45	971.51	-226.44
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-107.15	598.92	101.11	1,035.47	-252.08
Provision for Tax	0.03	107.42	-654.74	174.84	20.05
Profit after Tax (Net Income)	-107.18	491.50	755.85	860.62	-319.95
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Personalis (PSNL)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds	235.16	433.86	1,435.90	1,843.76	465.53
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Non-Current Liabilities	30.59	187.89	384.48	288.55	1,362.63
Current Liabilities	46.39	1,435.43	464.70	361.93	283.35
Total Liabilities	334.16	1,975.47	1,302.02	2,844.42	1,385.30

Assets ($ Mln)

	Personalis (PSNL)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets	67.08	1,006.90	895.24	1,243.41	440.60
Current Assets	245.05	1,050.29	1,389.84	1,250.82	1,671.41
Total Assets	334.16	1,975.47	1,302.02	2,844.42	1,385.30
Total Debt*	38.00	120.10	449.89	165.93	864.07
Net Current Assets	198.67	-385.14	0.00	888.90	1,388.07

Cashflow ($ Mln)

	Personalis (PSNL)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities	-74.95	713.22	51.77	884.27	179.55
Cash Flow from Investing Activities	-22.57	-31.14	-8.15	350.44	-129.29
Cash from Financing Activities	130.34	-860.39	34.89	-969.59	74.01
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Personalis (PSNL)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
ROCE (%)	-29.64	53.56	-30.01	32.82	-0.17
ROE (%)	-43.19	110.09	163.18	42.98	-71.14
ROA (%)	-33.03	15.64	26.53	29.32	-16.12
EBIT Margin (%)	-153.49	21.13	5.73	31.04	-0.77
Net Margin (%)	-153.84	17.67	71.69	35.33	-47.79
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Personalis (PSNL)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%)	-13.26	24.67	114.85	9.23	12.22
EBIT Growth (%)	-17.22	18.70	136.39	-3.99	93.17
Net Profit Growth (%)	-17.37	17.50	378.76	42.89	-115.58
EPS Growth (%)	14.26	26.84	353.27	50.42	-73.87
Book Value Growth (%)	3.47	164.02	816.12	-0.70	-13.57

Valuation Ratios

	Personalis (PSNL)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Price / Earnings	-9.04	36.06	-59.76	15.79	-2,869.63
Price / Book Value	2.81	35.44	-80.42	5.72	10.04
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	-7.53	28.08	-121.54	12.44	25.04
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Personalis (PSNL)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debt to Equity	0.00	0.00	0.00	0.00	1.77
Short term debt to equity ratio	0.03	0.00	0.05	0.00	0.09
Current Ratio	5.28	0.73	2.99	3.46	5.90
Quick Ratio	5.08	0.73	2.32	3.38	5.90
Interest Coverage	-502.03	--	1.62	--	-1.72

Operating Efficiency Ratios

	Personalis (PSNL)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%)	21.68	15.88	21.25	13.74	1.28
Asset Turnover	0.21	0.89	0.37	0.83	0.34
Receivable days	63.83	50.42	85.52	43.48	1.50
Inventory Days	34.31	--	1,056.70	96.17	--
Payable days	65.72	6.26	331.01	147.97	221.81
Cash Conversion Cycle	32.42	--	811.21	-8.32	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly